Former Multiple Sclerosis Fellow, Washington University in St. Louis, Current Neurologist, Mercy MS Care, St. Louis MO, USA.
Neurology Resident, Washington University in St. Louis, USA.
Mult Scler Relat Disord. 2019 Nov;36:101393. doi: 10.1016/j.msard.2019.101393. Epub 2019 Sep 9.
Surveys of people with multiple sclerosis (MS) report that most are interested in using dietary modifications to potentially reduce the severity and symptoms of their disease. This review provides an updated overview of the current state of evidence for the role of specific diets in MS and its animal models, with an emphasis on recent studies including efficacy and safety issues related to dietary manipulations in people with MS.
Studies were identified using a PubMed search for each diet in both MS and experimental autoimmune encephalomyelitis, by review of the reference list of papers identified in the search process, and by searching clinicaltrials.gov for ongoing studies. Each study was evaluated and the data was summarized. Each diet was assigned a level of evidence for its use in MS based on the Quality Rating Scheme for Studies and Other Evidence.
Several diets have been explored in people with MS and animal models of MS. Most human trials have been small and non-blinded, limiting their generalizability. Many have also been of short-duration, potentially limiting their ability to find clinically meaningful changes. Presently, insufficient evidence exists to recommend the routine use of any specific diet by people with MS. Clinical trials are ongoing or planned for many diets including the Swank Diet, Wahl's diet, McDougall diet, Mediterranean diet, and intermittent fasting. Results of these studies may help guide clinical recommendations.
There is insufficient evidence to recommend the routine use of any specific diet by people with MS. Some diets touted for MS may have potential negative health consequences. It is important that clinicians inquire regarding dietary manipulations, so they can educate patients on any known efficacy data and potential adverse effects of individual diets. Consultation with a registered dietician is recommended for patients undertaking restrictive diets.
对多发性硬化症(MS)患者的调查报告显示,大多数患者有兴趣通过饮食调整来降低疾病的严重程度和症状。本综述提供了当前特定饮食在 MS 及其动物模型中的作用的最新证据概述,重点是最近的研究,包括与 MS 患者饮食干预相关的疗效和安全性问题。
使用 PubMed 对 MS 和实验性自身免疫性脑脊髓炎中的每种饮食进行搜索,通过查阅搜索过程中确定的论文参考文献列表,并通过在 clinicaltrials.gov 上搜索正在进行的研究,来确定研究。评估了每项研究并总结了数据。根据研究和其他证据的质量评分方案,为每种饮食在 MS 中的使用分配证据级别。
已经在 MS 患者和 MS 动物模型中探索了几种饮食。大多数人体试验规模较小且未设盲,限制了其普遍性。许多试验的持续时间也较短,可能限制了发现具有临床意义的变化的能力。目前,没有足够的证据推荐 MS 患者常规使用任何特定的饮食。许多饮食包括斯旺饮食、瓦尔饮食、麦克杜格尔饮食、地中海饮食和间歇性禁食,目前正在进行或计划进行临床试验。这些研究的结果可能有助于指导临床建议。
没有足够的证据推荐 MS 患者常规使用任何特定的饮食。一些吹捧用于 MS 的饮食可能会产生潜在的健康负面影响。临床医生询问饮食干预措施非常重要,以便他们可以向患者介绍有关特定饮食的已知疗效数据和潜在不良反应。建议患者采用限制饮食的患者咨询注册营养师。